HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

Get your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
159 Doctors Online

By proceeding, I accept the Terms and Conditions

Dr. Andrew Rynne
MD
Dr. Andrew Rynne

Family Physician

Exp 50 years

HCM Blog Instant Access to Doctors
HCM BlogQuestions Answered
HCM Blog Satisfaction

Does Opdivo Decrease The Chances Of Recurrent Melanoma?

I have been fighting stage 3c melanoma. My last surgery removed all lymph nodes in my left groin. I am now cancer free. It was recommended I do a pro active plan using opdivo. I m 56 female and have no other health issues. Was given 35 to50 percent for cancer to return within 5 years. Using this drug may improve my odds by only 10 percent. Your thoughts ?
Mon, 16 Jul 2018
Report Abuse
Pulmonologist,  's  Response
Hello and Welcome to ‘Ask A Doctor’ service. I have reviewed your query and here is my advice.

Opdivo is having Nivolumab. It is very effective in metastatic melanoma. It has been shown to improve prognosis, decrease recurrence and relapse. So you should definitely start this newer monoclonal antibody. In my personal opinion, combination of ipilimumab and Opdivo show excellent results in terms of relapse. So better to discuss about this combination with your oncologist.

Hope I have answered your query. Let me know if I can assist you further.
I find this answer helpful
Note: For further follow up on related General & Family Physician Click here.
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer. For a more detailed, immediate answer, try our premium service [Sample answer]
Share on
 

Related questions you may be interested in


Loading Online Doctors....
Does Opdivo Decrease The Chances Of Recurrent Melanoma?

Hello and Welcome to ‘Ask A Doctor’ service. I have reviewed your query and here is my advice. Opdivo is having Nivolumab. It is very effective in metastatic melanoma. It has been shown to improve prognosis, decrease recurrence and relapse. So you should definitely start this newer monoclonal antibody. In my personal opinion, combination of ipilimumab and Opdivo show excellent results in terms of relapse. So better to discuss about this combination with your oncologist. Hope I have answered your query. Let me know if I can assist you further.